Related content

Activity of Gemcitabine in Platinum-resistant Ovarian Germ Cell Cancer

By Maas K.   Daikeler T.   Kanz L.   Bokemeyer C.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1437-1438

Elsevier

Access to resources Recommend Favorite

Platinum-Resistant and Refractory Ovarian Cancer: Second-Line Treatment Options

By Alvarez A.A.   Clarke-Pearson D.L.  

American Journal of Cancer, Vol. 2, Iss. 1, 2003-01 ,pp. : 1-13

Adis International

Access to resources Recommend Favorite

Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer

By Shim Hyun  

Gastric Cancer, Vol. 14, Iss. 3, 2011-08 ,pp. : 249-256

Springer Publishing Company

Access to resources Recommend Favorite

Heavily pretreated ovarian cancer patients treated by single-agent gemcitabine. A retrospective outcome comparison between platinum-sensitive and platinum-resistant patients

By Safra Tamar   Ron Ilan   Boaz Mona   Brenner Joseph   Grisaru Dan   Inbar Moshe   Hayat Henry   Menczer Joseph   Golan Abraham   Levy Tally  

Acta Oncologica, Vol. 45, Iss. 4, 2006-06 ,pp. : 463-468

Informa Healthcare

Access to resources Recommend Favorite

Complete remission of platinum-refractory primary Fallopian tube carcinoma with third-line gemcitabine plus cisplatin: A case report and review of the literature

By              

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1601-1604

Spandidos Publications

Access to resources Recommend Favorite